J 2017

Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up

STEPANKOVA, Lenka, Eva KRALIKOVA, Kamila ZVOLSKA, Alexandra PANKOVA, Petra OVESNÁ et. al.

Základní údaje

Originální název

Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up

Autoři

STEPANKOVA, Lenka (203 Česká republika), Eva KRALIKOVA (203 Česká republika), Kamila ZVOLSKA (203 Česká republika), Alexandra PANKOVA (203 Česká republika), Petra OVESNÁ (203 Česká republika, garant, domácí), Milan BLAHA (203 Česká republika, domácí) a Leonie S. BROSE (826 Velká Británie a Severní Irsko)

Vydání

ANNALS OF BEHAVIORAL MEDICINE, New York, Springer, 2017, 0883-6612

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

50101 Psychology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.118

Kód RIV

RIV/00216224:14110/17:00096930

Organizační jednotka

Lékařská fakulta

DOI

UT WoS

000401922100013

Klíčová slova anglicky

Smoking cessation; Depression; Cohort study; Preventive health services; Effectiveness; Evidence-based practice

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2018 12:14, Soňa Böhmová

Anotace

V originále

Smoking is more prevalent among people with depression. Depression may make cessation more difficult and cessation may affect depression symptoms. The aims of this study were to assess the associations between (1) baseline depression and 1-year smoking abstinence and (2) abstinence and change in depression. Observational study using data collected routinely in a smoking cessation clinic in the Czech Republic from 2008 to 2014. Aim 1: N = 3775 patients; 14.3% reported mild and 15.4% moderate/severe baseline depression levels measured using Beck's Depression Inventory (BDI-II). Logistic regressions assessed if depression level predicted 1-year biochemically verified abstinence while adjusting for patient and treatment characteristics. Aim 2: N = 835 patients abstinent at 1 year; change in depression was analysed using Chi-square statistics, t test and mixed method analyses of variance. Rate of abstinence was lower for patients with mild (32.5%, OR = 0.68; 95% CI: 0.54 to 0.87, p = 0.002) and moderate/severe depression (25.8%; OR = 0.57, 95% CI: 0.45 to 0.74, p < 0.001) compared with patients without depression (40.5%). Across abstinent patients, the majority with baseline depression reported lower depression levels at follow-up. Overall mean (SD) BDI-II scores improved from 9.2 (8.6) to 5.3 (6.1); t(834) = 14.6, p < 0.001. There were significant main effects of time (F(1832) = 880.8, p < 0.001, partial eta(2) = 0.51) and baseline depression level (F(2832) = 666.4, p < 0.001, partial eta(2) = 0.62) on follow-up depression and a significant depression * time interaction (F(2832) = 296.5, p < 0.001, partial eta(2) = 0.42). In this effective smoking cessation clinic, depression at the start of treatment predicted reduced smoking abstinence 1 year later. Patients abstinent from smoking experienced considerable improvement in depression.